(Sharecast News) - AstraZeneca and one of its main European suppliers have defended their Covid-19 vaccine production process after the European Medicines Agency said it was investigating potential defects in certain batches.
The EMA's inquiry follows concerns about blood clots and other possible side-effects that have prompted many European countries to...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE